TherapeuticsMD, Inc. (TXMD)

NMS – Цена в реальном времени. Валюта: USD

2.08

+0.01 (0.48%)

При закрытии: Aug 12, 2026, 4:00 PM EDT

2.05

-0.03 (-1.44%)

После закрытия: Aug 12, 2026, 6:18 PM EDT

11.08.2026

TherapeuticsMD Announces Second Quarter 2026 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the three months ended June 30, 2026. Second Quarter 2026 Financial Results Net Income from Continuing Operations Net income from continuing operations totaled $164 thousand, compared to net income of $545 thousand for the second quarter of 2025. License Revenues from Continuing Operations The Com.

Видео

No Data

There is no data to display

Пресс-релизы

11.08.2026

TherapeuticsMD, Inc. (TXMD)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

TherapeuticsMD, Inc. (TXMD)

TherapeuticsMD Announces Second Quarter 2026 Financial Results

Видео

No Data

Пресс-релизы

TherapeuticsMD Announces Second Quarter 2026 Financial Results

TherapeuticsMD Announces Second Quarter 2026 Financial Results

Видео

No Data

Пресс-релизы

TherapeuticsMD Announces Second Quarter 2026 Financial Results

Search stocks

TherapeuticsMD, Inc. (TXMD)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

TherapeuticsMD, Inc. (TXMD)

TherapeuticsMD Announces Second Quarter 2026 Financial Results

Видео

No Data

Пресс-релизы

TherapeuticsMD Announces Second Quarter 2026 Financial Results

TherapeuticsMD Announces Second Quarter 2026 Financial Results

Видео

No Data

Пресс-релизы

TherapeuticsMD Announces Second Quarter 2026 Financial Results